VACCITECH ONCOLOGY LIMITED

11655405
Active Altrincham

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
V

VACCITECH ONCOLOGY LIMITED

11655405

Research and experimental development on biotechnology

Founded 1 Nov 2018 Active Altrincham, United Kingdom 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 25 Apr 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 5 Feb 2026 Next due 4 Feb 2027 7 months remaining
Net assets £259K £98K 2025 year on year
Total assets £347K £789K 2025 year on year
Total Liabilities £88K £691K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for VACCITECH ONCOLOGY LIMITED (11655405), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 1 Nov 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2019–2025)

Cash in Bank

£342.00k

Decreased by £641.00k (-65%)

Net Assets

£259.00k

Decreased by £98.00k (-27%)

Total Liabilities

£88.00k

Decreased by £691.00k (-89%)

Turnover

N/A

Employees

N/A

Decreased by 3 (-100%)

Debt Ratio

25%

Decreased by 44 (-64%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 7,121 Shares £783k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Dec 20207,121£783k£110

Officers

Officers

1 active 2 resigned
Status
William James EnrightDirectorAmericanUnited States633 Oct 2019Active

Shareholders

Shareholders (2)

Barinthus Biotherapeutics (uk) Limited
76.0%
87,621
Ludwig Institute For Cancer Research Limited
24.0%
27,670

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 1 Nov 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

VACCITECH ONCOLOGY LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
25 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
13 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
5 Feb 2026Confirmation StatementConfirmation statement made on 21 Jan 2026 with no updates
24 Jan 2026OfficersAppointment of Mr Alexander Eric Hammacher as director
25 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

25 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

13 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

5 Feb 2026 Confirmation Statement

Confirmation statement made on 21 Jan 2026 with no updates

24 Jan 2026 Officers

Appointment of Mr Alexander Eric Hammacher as director

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 months ago on 25 Apr 2026

Annual accounts made up to 31 Dec 2025

2 months ago on 25 Apr 2026

Annual accounts made up to 31 Dec 2025

2 months ago on 13 Apr 2026

Confirmation statement made on 21 Jan 2026 with no updates

4 months ago on 5 Feb 2026

Appointment of Mr Alexander Eric Hammacher as director

5 months ago on 24 Jan 2026